31 Jul 2018 --- Adults with irritable bowel syndrome (IBS) show improvement from co-existing depression when taking the probiotic strain Bacillus coagulans MTCC 5856, Sabinsa’s LactoSpore, versus subjects given a placebo, according to a clinical study published in the journal Food & Nutrition Research. These findings hint at the possibility that LactoSpore may be a new treatment option for major depressive disorder in IBS patients and open new avenues for the probiotic’s use in gut and psychological conditions.